医学
肺
放射治疗
不利影响
腺癌
靶向治疗
放射性武器
肿瘤科
肺腺癌
内科学
放射科
癌症
作者
Yang Hong-yu,Huipan Liu,Yu Zhang,Yu Zhang,Yue Chen
标识
DOI：10.1097/rlu.0000000000005169
摘要
Abstract A 56-year-old man with metastatic lung adenocarcinoma received combined 177 Lu-FAP-2286 radiation therapy and targeted therapy. After 1 treatment cycle, improvement of symptoms and radiological remission was observed. Moreover, the patient did not report any adverse effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
Ivy
可千万不要躺平呀
从容芮
OCDer
wangrblzu
平常的毛豆
HEIKU
nenoaowu
AireenBeryl531
善良的剑通
孙燕
coolkid
zho
SYLH
scm
Whim
MchemG
VV小蛋糕
遇上就这样吧
皖公网安备34019202002308
